• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    J&J’s Single-Dose COVID-19 Vax Issued EUA

    Icon to Acquire PRA Health Sciences

    Phlow Corp. and USP Form Alliance

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology

    Solid Dose Market Trends

    CatSci Opens New Site in UK
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Icon to Acquire PRA Health Sciences

    BMS Expands Cell Therapy Manufacturing Capabilities

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Aphena Pharma Solutions

    Adare Pharma Solutions

    Alcami

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Cytovance Biologics

    PCI Pharma Services

    Emergent BioSolutions

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Getting to First-in-Human Clinical Trials

    A make-or-break milestone for small biopharmas

    Getting to First-in-Human Clinical Trials
    Related CONTENT
    • Asahi Kasei Pharma Contracts ProBioGen
    • Bionova Scientific Secures First Client Commitment
    • CDMOs: Keeping up with Science & Technology
    • AC Immune and WuXi Biologics Expand Strategic Partnership
    • Samsung Biologics Expands Global Footprint
    David Kenyon, Patheon10.10.18
    “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market quicker than ever before.

    The incentive of securing market share with first-to-market offerings is felt by all industry players. Pressure mounts from here for small companies, which often must meet certain milestones before receiving funding from investors. Quickly proving efficacy in first-in-human (FIH) trials is a make-or- break milestone for cash-strapped companies whose hopes for success hinge upon just one or two molecules.

    Speed and revenue are also intertwined at Large Pharma. As Large Pharma struggles with R&D productivity, companies need to fill pipelines with promising options. Many large biopharma companies have numerous molecules with therapeutic potential but screening them at the same time and determining the best ones to pursue in FIH trials is a huge challenge.

    Speed to market takes on even greater urgency when you consider that many biopharmaceuticals are intended for treating chronic, serious and/or life-threatening conditions. Many patients cannot wait years for therapies to enter the clinic and come to market.

    Thus, whether biopharmaceutical companies have one candidate or 100, the directive is clear: moving quickly into FIH testing is essential. But, how?

    Key strategies for speeding time to clinic
    In response to this pressure, CDMOs are focusing on reducing timelines for producing high-quality clinical supply. For instance, our team recently launched the Quick to Clinic program for biologics, which uses three chief elements to help move from cell line development to drug substance for clinical trials in as little as 14 months.

    Cell line development flexibility is important. When sponsor clients are restricted to using only the CDMO’s proprietary cell line and media for development product services, their flexibility to make strategic manufacturing decisions is greatly limited. It’s important to offer clients options that are best suited to their molecule’s needs. With the Quick to Clinic approach, clients can use their own cell line or ours. In either scenario, it’s important follow a pre-established set of parameters for process development that gives clients flexibility, remove certain mandatory fees, and make more efficient use of critical preclinical time. Alternatively, we can work with our client’s cell line and develop a slightly longer, more custom route.

    Companies can move to the clinic faster and less expensively if they use one qualified CDMO partner to seamlessly take a project from cell line development to a released drug substance and into drug product. In addition to better communication, clients can benefit from parallel development. While collecting stability data to file an IND, CDMOs with broad experience can start working on product filling/packaging/labeling, for instance. Likewise, CDMOs that can couple drug substance and drug product manufacturing save assay transfer costs and time since they can provide testing for both. Other benefits come from more efficient production scheduling.

    Now, being part of Thermo Fisher Scientific, Patheon can take advantage of Thermo Fisher’s range of nutritional medias for CHO and other cells as well as Poros Cation Exchange Resins to help reduce the time it takes to move from drug substance to product.

    Every day a drug is not on the market equates to lost revenue and delays in a patient from feeling better. Time matters, and so does the flexibility and expertise a CDMO can offer for getting to FIH testing as fast as possible.


    David Kenyon
    Patheon

    David Kenyon is Senior Director of Scientific and Technical Affairs at Patheon, part of Thermo Fisher Scientific.
    Related Searches
    • Preclinical
    • Clinical Trials
    • Process Development
    • CDMO
    Suggested For You
    Asahi Kasei Pharma Contracts ProBioGen Asahi Kasei Pharma Contracts ProBioGen
    Bionova Scientific Secures First Client Commitment Bionova Scientific Secures First Client Commitment
    CDMOs: Keeping up with Science & Technology CDMOs: Keeping up with Science & Technology
    AC Immune and WuXi Biologics Expand Strategic Partnership AC Immune and WuXi Biologics Expand Strategic Partnership
    Samsung Biologics Expands Global Footprint Samsung Biologics Expands Global Footprint
    ImmunOs Uses ProBioGen’s Pathway Modulator Technology ImmunOs Uses ProBioGen’s Pathway Modulator Technology
    ProBioGen, Heidelberg Pharma Ink ATAC Agreement ProBioGen, Heidelberg Pharma Ink ATAC Agreement
    JSR Life Sciences Expands European Footprint JSR Life Sciences Expands European Footprint
    Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
    Rentschler Biopharma and ATUM Ink Licensing Agreement Rentschler Biopharma and ATUM Ink Licensing Agreement
    KindredBio Expands Manufacturing Agreement with Vaxart KindredBio Expands Manufacturing Agreement with Vaxart
    Kindred Bio Expands Agreement with Vaxart Kindred Bio Expands Agreement with Vaxart
    Samsung Biologics Adopts Solentim Solutions in R&D Center Samsung Biologics Adopts Solentim Solutions in R&D Center
    Cytovance, Horizon Sign License Agreement Cytovance, Horizon Sign License Agreement
    Just Biotherapeutics, Pandion Enter Product Devt. and Mfg. Agreement Just Biotherapeutics, Pandion Enter Product Devt. and Mfg. Agreement

    Related Back Page

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20

    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19


    • Biologics, Proteins, Vaccines | Biosimilars
      Biogenerics Progress

      Biogenerics Progress

      Generic makers target big forays into major markets
      S. Harachand, Contributing Editor 06.12.18

    • Clinical Trials

      CRO Revenues Are Being Jeopardized By Calls Not Connecting

      CRO revenues are being jeopardized
      Stephen Levenson, Global Telecom Testing 06.02.16

    • Clinical Trials

      Door-to-door Service and Telemedicine

      How innovative approaches are changing the way patients are recruited into rare disease trials
      Cynthia Jackson, Pediatric Center of Excellence 05.05.16


    • Clinical Trials | Drug Development | Supply Chain

      Investing in Big Data-Driven Risk-Based Monitoring

      Benefits of Big Data include managing risk and improving operational efficiency
      Kyle Given, Medidata 05.06.15

    • Clinical Trials | Validation

      Where is the “Quality” in GCP?

      Collaboration is key in conducting successful clinical trials
      Suzanne Tran, Technical Resources International 04.01.15

    • Clinical Trials | Drug Development

      Five Predictions for 2015

      What’s next for clinical data management and investments?
      Rick Morrison, Comprehend Systems 01.29.15


    • Clinical Trials | Drug Development

      Generic Company CEOs: 505(b)(2)

      Development strategy to drive growth
      Ken Phelps, Camargo Pharmaceutical Services 04.03.14

    • Clinical Trials | Drug Development

      The Power of the Cloud

      ...
      Rick Morrison, Comprehend Systems 03.07.14

    • Clinical Trials | GMPs/GCPs | Inspections | Regulatory Affairs

      Orphan Drugs

      Increasing reimbursement and commercialization barriers
      Anthony Harrington, Results Healthcare 11.13.13


    • Aseptic Processing | Cleaning Validation | Clinical Trials | Extractables and Leachables | Facilities | GMPs/GCPs | Inspections | Methods Development | Microbiology | Parenterals | Process Development | QA/QC | Validation

      The Next Generation CMOs

      Aseptic processing designs must advance
      Jason S. Collins, IPS-Integrated Project Services 10.09.13

    Trending
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    • The Future Of Vaccines And Biologics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • J&J’s Single-Dose COVID-19 Vax Issued EUA
    • Icon to Acquire PRA Health Sciences
    • Phlow Corp. and USP Form Alliance
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Novo Nordisk Invests $80M in Tablet Production
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Gelest CEO Elected to National Academy of Engineering
    PPG Appoints Tony Wu as VP, Automotive Refinish, Asia
    PPG Appoints John Bruno as VP, Investor Relations
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login